News

Releases

19. April, 2021

First quarter report Q1-2021 – ‘one down, two to go’ of the major milestones of 2021

Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1...

Read more

Media

26. March, 2021

Cessatech utvecklar nästa generations smärtlindring för barn

Cessatech är ett danskt läkemedelsbolag specialiserat på forskning och utveckling av smärtstillande nässpray som...

Read more

Releases

24. March, 2021

Cessatech reports first subject dosed in bioavailability trial of lead product candidate

Clinical trial 0204 in healthy volunteers will investigate the absolute bioavailability of CT001. Primary...

Read more

Releases

9. March, 2021

Cessatech A/S is awarded Best Medical Treatment IPO Nordics in 2020 by independent editorial

CFI.co – a journal and online resource reporting on business, economics and finance –...

Read more

Releases

4. March, 2021

Favourable data from the Registry Safety Study

First major milestone reached: Data from the Registry Safety Study (0203) indicates a favourable...

Read more

Releases

11. February, 2021

Year-end report Q4-2020 – on track and accelerating clinical activities

Cessatech A/S today releases its results for the period 6. April – 31 December 2020. The company is on track with Q4 activities and getting...

Read more

Facts

2. February, 2021

Ny forskning: Barn bör få smärtlindring vid vaccinationer och injektioner

Barn mår bra av smärtlindring vid vanliga vaccinationer och injektioner. Det säger den senaste...

Read more

Releases

21. January, 2021

Supporting ‘Save the Children’

Cessatech has entered a corporate sponsorship with Save the Children. We want to make...

Read more

Media

27. November, 2020

Massiv interesse for børsnotering

Det nystiftede bioselskab Cessatech med en tidligere Lundbeck-direktør i spidsen og prominente folk i...

Read more

Releases

27. November, 2020

Cessatech’s IPO of units significantly oversubscribed

Subscribed to DKK 107 million, corresponding to a subscription ratio of approx. 680 percent....

Read more

Media

24. November, 2020

CESSATECH VILL BEDÖVA BARN VIA NÄSAN

STOCKHOLM (Nyhetsbyrån Direkt) Det danska forskningsbolaget Cessatech, som utvecklar behandlingar för barn, tänker ge...

Read more

Media

10. November, 2020

Cessatech mot börsen med nässpray mot smärta

Danska Cessatech har utvecklat en nässpray för smärtlindring speciellt anpassad för barn. Den ska...

Read more

Stay up to date!

Subscribe and get notified on Cessatech's latest news.